Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Cambridge
State: Massachusetts
Zip:
Country: United States
Q32 Bio is a biotechnology company developing treatments for patients with severe autoimmune and inflammatory diseases. Q32 Bio is addressing dysregulation to help patients take back control of their lives in diseases with few to no treatment options, or those diseases where current therapeutics provide inadequate relief. Q32 Bio consists of a team of scientists and industry veterans with strong expertise in immunology. The team has a strong track record of discovering and developing new and innovative therapies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2020 | Series B | 8 | $60M |
Abingworth Acorn Bioventures Atlas Venture Children’s Hospital Colorado OrbiMed OUP (Osage University Partners) Sanofi Ventures University of Colorado Abingworth Acorn Bioventures Atlas Venture Children’s Hospital Colorado OrbiMed OUP (Osage University Partners) Sanofi Ventures University of Colorado |
5/2020 | Series A | 6 | $46M |
Abingworth Atlas Venture Children’s Hospital Colorado OrbiMed Sanofi Ventures University of Colorado Abingworth Atlas Venture Children’s Hospital Colorado OrbiMed Sanofi Ventures University of Colorado |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|